Frankfurt - Delayed Quote EUR
Cipher Pharmaceuticals Inc. (PHE.F)
7.55
+0.05
+(0.67%)
As of 8:01:24 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in CAD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 4 | 4 | 4 | 3 |
Avg. Estimate | 17.14M | 18.2M | 72.34M | 78.5M |
Low Estimate | 15.85M | 16.74M | 67.1M | 77.79M |
High Estimate | 18.49M | 20.18M | 77.64M | 79.74M |
Year Ago Sales | 8.03M | 7.29M | 47.72M | 72.34M |
Sales Growth (year/est) | 113.47% | 149.59% | 51.59% | 8.52% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
PHE.F | -- | -- | -- | -- |
S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
Upgrade | Stifel: Hold to Speculative Buy | 6/1/2023 |
Related Tickers
R5XA.BE AcelRx Pharmaceuticals Inc
0.4205
0.00%
TEVA.VI Teva Pharmaceutical Industries Limited
12.90
+1.57%
EIIA.F Eisai Co Ltd
5.90
0.00%
MB8.F Moberg Pharma AB (publ)
0.6740
-1.53%
LDZU.F Aspen Pharmacare Holdings Limited
5.40
+8.00%
EVT.VI Evotec SE
7.25
-1.25%
I7G.F Ipsen S.A.
98.25
+4.35%
ROVI.VI Laboratorios Farmaceuticos Rovi, S.A.
51.05
+0.10%
UTH.F United Therapeutics Corporation
261.10
+1.75%
PXS.L Provexis plc
0.5500
0.00%